Lexaria Bioscience Corp. (LEXX) stock
LEXXNasdaqPharmaceutical PreparationsFiscal year ends August 31
$4.28+0.10 (+2.39%)
Close on Nov 18, 2026Market cap $106.09MP/E –Yield –
Lexaria Bioscience market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Lexaria Bioscience's market cap was $115.01M on Nov 11, 2026, against $319.78M a year earlier. Over the last 5 years it ranged from $65.19M to $969.91M, with a median of $262.69M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $115.01M | -36.5% |
| 2025 | Dec 31, 2025 | $181.01M | -70.6% |
| 2024 | Dec 31, 2024 | $616.08M | +306.1% |
| 2023 | Dec 29, 2023 | $151.71M | -30.9% |
| 2022 | Dec 30, 2022 | $219.58M | -36.6% |
| 2021 | Dec 31, 2021 | $346.16M | +2.8% |
| 2020 | Dec 31, 2020 | $336.74M | -25.5% |
| 2019 | Dec 31, 2019 | $452.06M | -57.1% |
| 2018 | Dec 31, 2018 | $1.05B | -38.9% |
| 2017 | Dec 29, 2017 | $1.72B | +622.5% |
| 2016 | Dec 30, 2016 | $238.50M | – |
See a number that looks wrong?